Home page > Europe and Health | Health, wealth and equity | Health friendly research and innovation | EU Funding and programmes | Irish Presidency priorities


Please find all related articles below.

FP7 : MEPs targeted to increase funding for rheumatism

Sponsored by the Member of the Europea Parliament (MEP) Ursula Stenzel (EPP- AU), EULAR - the European League Against Rheumatism - organised a conference in the European Parliament. They asked MEPs to consider rheumatism as a major disease in the future FP7, which will allow rheumatic disease to benefit from a special budget line. After a video message from the Commissioner for Research, Janez Potocnik, 8 speakers (including 2 speakers from pharmaceutical companies) repeated the need to (...)
Also about: Chronic Diseases

Commission report on the challenges of biometrics

The Commission has published the report ’Biometrics at the Frontiers: Assessing the Impact on Society’. The study assesses how biometric technologies, like fingerprinting and iris and face recognition, will impact on our daily lives. The report is published in the context of the new EU requirement for biometric passports, visas and residence permits from 2006. Biometrics are often thought of only in terms of security and border controls, but the report makes the claim that (...)

Bioethics at stake in the new FP7

The European Commission encounters a sound opposition from the European Parliament to introducing European funding for research on human embryo and embryonic stem cells in the next 7th Research Framework Programme (FP7). On the 20 September 2005, a group of 73 MEPs have signed a letter to the European Commission President, Manuel Barroso, calling the Commission to respect the principle of subsidiarity in the matter: Member States should decide if they want to fund research on the human (...)
Also about: Biotechnology

New tool for scientific input into policy-making

The Commission has launched a new e-Network designed to make scientific advice more available to policy-makers at the EU and national level called SINAPSE (Scientific Information for Policy Support in Europe). The new web-platform is to promote and encourage exchange of information between policy-makers and the scientific community. It will aim to be: A library of scientific opinion and advice A tool for the Commission to consult the scientific community An early-warning system A (...)
Also about:

Health Action International on European medicines’ policy

Health Action International-Europe (HAI), an EPHA member, has recently published three new position papers on key issues affecting European medicines’ policy. "Running on empty: Medicines’ production and the absence of innovation" lays out HAI’s view that the pharmaceutical industry does not and will not produce medicines geared to public need - i.e. geared to priority conditions, at affordable prices and of genuine therapeutic advance. It concludes by urging (...)

Petition to WHO on research and development of medicines

On 24 February 2005, 162 non-governmental organisations, academics and politicians issued an open letter urging the World Health Organisation to evaluate the draft Medical Research and Development Treaty that has been drawn up over the past two years by a group of economists, scientists and public health experts Existing trade agreements designed to bolster medical R&D investments focus nearly exclusively on stronger intellectual property rights and higher drug prices. This approach (...)

EU scientists find no link between parabens and breast cancer

Parabens are a group of chemicals widely used as preservatives in food products, medicines and cosmetics such as lipsticks and deodorants. The Cosmetic Directive of 1976 sets the maximum concentration for their use in cosmetic products. Since then, a number of scientific publications have suggested a link between breast cancer and the use of paraben-containing deodorants and antiperspirants. DG SANCO requested an opinion from the Scientific Committee on Consumer Products (SCCP) . The (...)

Third Ministerial Conference on eHealth

eHealth is the use of information technologies, especially the Internet, to enhance the quality and accessibility of health services. Applications range from simple administrative tools such as managing patient databases to complex clinical applications which can support the clinician in diagnosis and treatment. As part of an overall approach to increasing the uptake of new technologies, the European Commission has managed an eHealth programme for several years. The third Ministerial (...)
Also about: Healthcare services

New Call for Proposals for EU funding on Emerging Science and Technology

The European Commission’ s DG Research has launched a call for proposals under the budgetline New and Emerging Science and Technology (NEST). The deadline for application is April 13 2005. INSIGHT projects INSIGHT projects must demonstrate an anticipatory function. They are scientific investigations designed to provide identification and clarification of discoveries and phenomena that could lead to potential risks for the society. They should aim at developing scientific (...)
Also about: EU Institutions

Exploring the future of ’Science Shops’

The European Commission hosted a conference to review the successes of a network of Science Shops and explored opportunities to enlarge the network of partners. The EPHA Secretariat attended the meeting organised by the DG Research together with representatives from NGO’s, Universities and existing Science Shops from throughout Europe. Science shops are organisations created as mediators between citizen groups (trade unions, pressure groups, non-profit organisations, social groups, (...)
Also about: Civil Society